The discovery research center could uncover molecular markers that enable new diagnostics and lead to potential therapies for people living with neurological complications related to HIV.
Weill Cornell Medicine investigators have determined the mechanism by which a molecule within cells can help tune the light sensitivity of the eyes, a finding that should enable the development of drugs that target this site to treat related eye diseases.
Chronic stress may contribute to the pain and urinary symptoms experienced by people with interstitial cystitis/bladder pain syndrome by triggering changes in the bladder and nervous system, according to Weill Cornell investigators.
Cornell researchers have developed a portable diagnostic test that can simultaneously detect and distinguish Ebola and Lassa, two serious viruses whose early symptoms can be difficult to tell apart.
The biologic drug interferon-alpha can benefit patients with blood cancers called myeloproliferative neoplasms by forcing mutant blood stem cells to become shorter-lived white blood cells.
Fungal diseases can contribute up to 20% of staple crop losses and drug-resistant fungal infections lead to some 3.8 million human deaths, globally per year.
Metabotropic glutamate receptors interact in varied ways with their principal regulatory proteins, according to Weill Cornell Medicine investigators. The findings could inform treatments for epilepsy, depression and anxiety disorders.
